ABVC BioPharma, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
ABVC BioPharma, Inc. (ABVC) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $225.74 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-15.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-03-13
- ABVC BioPharma, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-09-30 was $225.74K, a 0.00% change year-over-year.
- ABVC BioPharma, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-09-30 was $225.74K.
- ABVC BioPharma, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $1.24M, a 53.58% decline from fiscal 2021.
- ABVC BioPharma, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2021 was $2.68M, a 56.77% increase from fiscal 2020.
- ABVC BioPharma, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2020 was $1.71M.
- ABVC BioPharma, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2012 was $196.12K, a 73.51% decline from fiscal 2011.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2023-09-30 | $225.74K 10-Q · filed 2023-11-15 | ||
| 2023-06-30 | $451.48K 10-Q · filed 2023-11-15 | ||
| 2022-12-31 | $1.24M 10-K · filed 2024-03-13 | ||
| 2022-09-30 | $225.74K 10-Q · filed 2023-11-15 | ||
| 2022-06-30 | $451.48K 10-Q · filed 2023-11-15 | ||
| 2021-12-31 | $2.68M 10-K · filed 2022-03-31 | ||
| 2020-12-31 | $1.71M 10-K · filed 2022-03-31 | ||
| 2012-09-30 | $196.12K 10-K · filed 2015-04-16 | ||
| 2011-09-30 | $740.24K 10-K · filed 2015-04-15 |